ATRA - Atara Biotherapeutics, Inc.
5.17
0.170 3.288%
Share volume: 3,201,173
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$5.00
0.17
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-12-2024 | 03-07-2025 | 05-15-2025 | 08-11-2025 | 11-12-2025 | |
| Assets | ||||||||
| Total Assets | 165.272 M | 117.284 M | 142.706 M | 109.098 M | 62.038 M | 36.902 M | 30.167 M | |
| Current Assets | 106.434 M | 62.410 M | 91.855 M | 64.894 M | 27.182 M | 24.772 M | 18.432 M | |
| Inventories | 16.084 M | 18.749 M | 13.980 M | 10.655 M | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 8.131 M | 5.801 M | 9.205 M | 10.115 M | 4.320 M | 2.449 M | 2.807 M | |
| Short Term Investments | 11.152 M | 3.978 M | 20.736 M | 17.466 M | 0.000 | 5.420 M | 7.970 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 35.087 M | 31.314 M | 46.453 M | 25.030 M | 13.841 M | 16.903 M | 5.742 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 2.989 M | 2.317 M | 1.661 M | 1.294 M | 285.000 K | 176.000 K | 147.000 K | |
| Other Assets | 55.849 M | 52.557 M | 49.190 M | 42.910 M | 34.571 M | 11.954 M | 11.588 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 165.272 M | 117.284 M | 142.706 M | 109.098 M | 62.038 M | 36.902 M | 30.167 M | |
| Total liabilities | 263.580 M | 228.152 M | 233.245 M | 206.381 M | 117.110 M | 71.943 M | 66.801 M | |
| Total current liabilities | 180.690 M | 148.267 M | 155.979 M | 134.574 M | 47.892 M | 14.563 M | 18.057 M | |
| Accounts Payable | 2.854 M | 5.253 M | 2.146 M | 4.367 M | 1.384 M | 1.762 M | 318.000 K | |
| Other liabilities | 82.171 M | 79.318 M | 76.796 M | 71.807 M | 69.218 M | 57.380 M | 48.744 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 82.171 M | 79.318 M | 76.796 M | 71.807 M | 69.218 M | 57.380 M | 48.744 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -98.308 M | -110.868 M | -90.539 M | -97.283 M | -55.072 M | -35.041 M | -36.634 M | |
| Common stock | 1.903 B | 1.909 B | 1.951 B | 1.957 B | 1.961 B | 1.979 B | 1.982 B | |
| Retained earnings | -2.001 B | -2.020 B | -2.042 B | -2.055 B | -2.017 B | -2.014 B | -2.018 B |